Professor Ludmila Danilowicz-Szymanowicz

Back

Professor Ludmila Danilowicz-Szymanowicz

Medical University of Gdansk, Gdansk (Poland)

Member of:

European Association of Cardiovascular Imaging

Presentations Articles

Identifying the right candidates for the appropriate device therapies. How to maximise outcomes for your patients with cardiac resynchronisation therapy and implantable cardiac monitor

Event: ESC Congress 2025

Topic: Device Therapy

Session: Identifying the right candidates for the appropriate device therapies. How to maximise outcomes for your patients with cardiac resynchronisation therapy and implantable cardiac monitor

Access

Identification of patients with mitral annular disjunction and the highest risk of ventricular arrhythmias using advanced echocardiography tools

Event: EHRA 2025

Topic: Diagnostic Methods

Session: Ventricular arrhythmias risk prediction

Access

Segmental longitudinal strain and regional myocardial work index could help identify mitral valve prolapse patients with increased risk of ventricular arrhythmia

Event: EACVI 2023

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Mitral Valve Disease 2

Access

Can 2D speckle tracking echocardiography have an additional impact on prediction of hospitalizations due to heart failure decompensation in patients with ischemic left ventricular systolic dysfunction

Event: EuroEcho 2019

Topic: Systolic and Diastolic Function

Session: Imaging: systolic and diastolic function

Access

What is new in the assessment of patients with hereditary hemochromatosis - can 2D speckle tracking echocardiography be helpful in the early detection of heart abnormalities?

Event: EuroEcho 2019

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Tissue Doppler, Speckle Tracking and Strain Imaging

Access

Conventional and speckle-tracking echocardiographic assessment of patients with newly diagnosed hereditary haemochromatosis with consideration of age

Event: EuroEcho-Imaging 2018

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Tissue Doppler, Speckle Tracking and Strain Imaging

Access

Can two-dimensional speckle tracking echocardiography be useful for myocardial fibrosis prediction in patients with hypertrophic cardiomyopathy?

Event: EuroEcho-Imaging 2018

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: Insights in hypertrophic cardiomyopathy

Access

Can two-dimensional speckle tracking echocardiography be useful for the left ventricular assessment in the early stages of hereditary hemochromatosis?

Event: EuroEcho-Imaging 2016

Topic: Clinical applications

Session: Tissue Doppler and speckle tracking

Access

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Professor Ludmila Danilowicz-Szymanowicz Follow

Contributor content

Identifying the right candidates for the appropriate device therapies. How to maximise outcomes for your patients with cardiac resynchronisation therapy and implantable cardiac monitor

Identification of patients with mitral annular disjunction and the highest risk of ventricular arrhythmias using advanced echocardiography tools

Segmental longitudinal strain and regional myocardial work index could help identify mitral valve prolapse patients with increased risk of ventricular arrhythmia

Can 2D speckle tracking echocardiography have an additional impact on prediction of hospitalizations due to heart failure decompensation in patients with ischemic left ventricular systolic dysfunction

What is new in the assessment of patients with hereditary hemochromatosis - can 2D speckle tracking echocardiography be helpful in the early detection of heart abnormalities?

Conventional and speckle-tracking echocardiographic assessment of patients with newly diagnosed hereditary haemochromatosis with consideration of age

Can two-dimensional speckle tracking echocardiography be useful for myocardial fibrosis prediction in patients with hypertrophic cardiomyopathy?

Can two-dimensional speckle tracking echocardiography be useful for the left ventricular assessment in the early stages of hereditary hemochromatosis?

ESC 365 is supported by

Professor Ludmila Danilowicz-Szymanowicz